INBX
Inhibrx Bio (INBX)
NASDAQ
$95.17+$1.87 (+2.00%)
Price as of Jun 23, 2026 11:43 AM EDT
  • $1.4B
    Market Cap
  • 540.80%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
1.3M
+550.00%
200,000
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
1.3M
+550.00%
200,000
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-113.0M
-44.52%
-203.7M
N/A
Depreciation and Amortization Expense
2.5M
+8.67%
2.3M
N/A
Total Operating Expenses
136.3M
-58.89%
331.6M
N/A
Operating Profit
-135.0M
-59.26%
-331.4M
N/A
Interest Income
7.5M
-31.00%
10.9M
N/A
Interest Expense
-12.2M
-9.63%
-13.5M
N/A
Interest Income and Expense and Net
-4.7M
+81.68%
-2.6M
N/A
Total Nonoperating Income and Expense
-5.0M
-100.25%
2.0B
N/A
Income before Taxes
-140.1M
-108.30%
1.7B
N/A
Income Taxes
2,000
0.00%
2,000
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-140.1M
-108.30%
1.7B
N/A
Net Income from Continuing Operations Applicable to Common
-140.1M
-108.30%
1.7B
N/A
Basic EPS and Net Income
-9.04
-107.93%
114.01
N/A
Diluted EPS and Net Income
-9.04
-108.03%
112.62
N/A
Basic Weighted Average Shares
15.5M
+4.63%
14.8M
N/A
Diluted Weighted Average Shares
15.5M
+3.36%
15.0M
N/A
Balance Sheet
Cash and Cash Equivalents
124.2M
-18.60%
152.6M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
124.2M
-18.60%
152.6M
N/A
Total Current Assets
132.8M
-17.19%
160.4M
N/A
Accumulated Depreciation
11.1M
+25.05%
8.9M
N/A
Property and Plant and Equipment and Net
3.7M
-39.79%
6.2M
N/A
Total Long-Term Assets
4.4M
-35.91%
6.8M
N/A
Total Assets
146.5M
-18.97%
180.8M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
33.8M
-17.02%
40.7M
N/A
Total Long-Term Debt
100.6M
N/A
0
N/A
Total Long-Term Liabilities
104.7M
+1,522.28%
6.5M
N/A
Total Liabilities
138.5M
+193.51%
47.2M
N/A
Retained Earnings
-246.2M
+131.96%
-106.1M
N/A
Total Stockholders Equity
8.0M
-94.02%
133.6M
N/A
Total Shares Outstanding
14.6M
+0.70%
14.5M
N/A
Cash Flow
Cash from Operating Activities
-129.8M
-33.24%
-194.4M
N/A
Capital Expenditures
31,000
-98.81%
2.6M
N/A
Cash from Investing Activities
-28,000
-98.92%
-2.6M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
101.4M
+41.53%
71.7M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
-10,386.54%
N/A
N/A
N/A
Return on Assets
-85.60%
N/A
N/A
N/A
Return on Equity
-197.85%
N/A
N/A
N/A
Revenue Growth
550.00%
N/A
N/A
N/A
Current Ratio
3.93
N/A
N/A
N/A
Cash Ratio
3.68
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow